Marion McCourt - Nov 4, 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP Commercial
Signature
/s/** Marion McCourt
Stock symbol
REGN
Transactions as of
Nov 4, 2022
Transactions value $
-$355,360
Form type
4
Date filed
11/7/2022, 03:05 PM
Previous filing
Nov 2, 2022
Next filing
Dec 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $372K +1K +5.09% $372.46 20.6K Nov 4, 2022 Direct
transaction REGN Common Stock Sale -$728K -1K -4.84% $727.82 19.6K Nov 4, 2022 Direct
holding REGN Common Stock 138 Nov 4, 2022 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -1K -8.37% $0.00 11K Nov 4, 2022 Common Stock 1K $372.46 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option award vests in four equal annual installments, commencing one year after the date of grant.